BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 22064478)

  • 21. The prolyl isomerase Pin1 enhances HER-2 expression and cellular transformation via its interaction with mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1.
    Khanal P; Namgoong GM; Kang BS; Woo ER; Choi HS
    Mol Cancer Ther; 2010 Mar; 9(3):606-16. PubMed ID: 20179161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proline cis/trans-isomerase Pin1 regulates peroxisome proliferator-activated receptor gamma activity through the direct binding to the activation function-1 domain.
    Fujimoto Y; Shiraki T; Horiuchi Y; Waku T; Shigenaga A; Otaka A; Ikura T; Igarashi K; Aimoto S; Tate S; Morikawa K
    J Biol Chem; 2010 Jan; 285(5):3126-32. PubMed ID: 19996102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COT phosphorylates prolyl-isomerase Pin1 to promote tumorigenesis in breast cancer.
    Kim G; Khanal P; Kim JY; Yun HJ; Lim SC; Shim JH; Choi HS
    Mol Carcinog; 2015 Jun; 54(6):440-8. PubMed ID: 24265246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural and Molecular Mechanisms of Cytokine-Mediated Endocrine Resistance in Human Breast Cancer Cells.
    Stender JD; Nwachukwu JC; Kastrati I; Kim Y; Strid T; Yakir M; Srinivasan S; Nowak J; Izard T; Rangarajan ES; Carlson KE; Katzenellenbogen JA; Yao XQ; Grant BJ; Leong HS; Lin CY; Frasor J; Nettles KW; Glass CK
    Mol Cell; 2017 Mar; 65(6):1122-1135.e5. PubMed ID: 28306507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer.
    Rustighi A; Tiberi L; Soldano A; Napoli M; Nuciforo P; Rosato A; Kaplan F; Capobianco A; Pece S; Di Fiore PP; Del Sal G
    Nat Cell Biol; 2009 Feb; 11(2):133-42. PubMed ID: 19151708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complete thermodynamic and kinetic characterization of the isomer-specific interaction between Pin1-WW domain and the amyloid precursor protein cytoplasmic tail phosphorylated at Thr668.
    De S; Greenwood AI; Rogals MJ; Kovrigin EL; Lu KP; Nicholson LK
    Biochemistry; 2012 Oct; 51(43):8583-96. PubMed ID: 23025283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptidyl-prolyl cis/trans isomerase Pin1 is critical for the regulation of PKB/Akt stability and activation phosphorylation.
    Liao Y; Wei Y; Zhou X; Yang JY; Dai C; Chen YJ; Agarwal NK; Sarbassov D; Shi D; Yu D; Hung MC
    Oncogene; 2009 Jul; 28(26):2436-45. PubMed ID: 19448664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pin1: a multi-talented peptidyl prolyl cis-trans isomerase and a promising therapeutic target for human cancers].
    Marsolier J; Weitzman JB
    Med Sci (Paris); 2014; 30(8-9):772-8. PubMed ID: 25174754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amurensin G inhibits angiogenesis and tumor growth of tamoxifen-resistant breast cancer via Pin1 inhibition.
    Kim JA; Kim MR; Kim O; Phuong NT; Yun J; Oh WK; Bae K; Kang KW
    Food Chem Toxicol; 2012 Oct; 50(10):3625-34. PubMed ID: 22842120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prolyl isomerase Pin1 regulates hypoxia-inducible transcription factor (HIF) activity.
    Jalouli M; Déry MA; Lafleur VN; Lamalice L; Zhou XZ; Lu KP; Richard DE
    Cell Signal; 2014 Aug; 26(8):1649-56. PubMed ID: 24726894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of angiogenesis by quercetin in tamoxifen-resistant breast cancer cells.
    Oh SJ; Kim O; Lee JS; Kim JA; Kim MR; Choi HS; Shim JH; Kang KW; Kim YC
    Food Chem Toxicol; 2010 Nov; 48(11):3227-34. PubMed ID: 20804812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional conservation of phosphorylation-specific prolyl isomerases in plants.
    Yao JL; Kops O; Lu PJ; Lu KP
    J Biol Chem; 2001 Apr; 276(17):13517-23. PubMed ID: 11118438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgen receptor serine 81 mediates Pin1 interaction and activity.
    La Montagna R; Caligiuri I; Maranta P; Lucchetti C; Esposito L; Paggi MG; Toffoli G; Rizzolio F; Giordano A
    Cell Cycle; 2012 Sep; 11(18):3415-20. PubMed ID: 22894932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. OCT-4: a novel estrogen receptor-α collaborator that promotes tamoxifen resistance in breast cancer cells.
    Bhatt S; Stender JD; Joshi S; Wu G; Katzenellenbogen BS
    Oncogene; 2016 Nov; 35(44):5722-5734. PubMed ID: 27065334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting Pin1 by All-Trans Retinoic Acid (ATRA) Overcomes Tamoxifen Resistance in Breast Cancer via Multifactorial Mechanisms.
    Huang S; Chen Y; Liang ZM; Li NN; Liu Y; Zhu Y; Liao D; Zhou XZ; Lu KP; Yao Y; Luo ML
    Front Cell Dev Biol; 2019; 7():322. PubMed ID: 31867329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer.
    Ryo A; Liou YC; Lu KP; Wulf G
    J Cell Sci; 2003 Mar; 116(Pt 5):773-83. PubMed ID: 12571275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pin1 promotes transforming growth factor-beta-induced migration and invasion.
    Matsuura I; Chiang KN; Lai CY; He D; Wang G; Ramkumar R; Uchida T; Ryo A; Lu K; Liu F
    J Biol Chem; 2010 Jan; 285(3):1754-64. PubMed ID: 19920136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production.
    Pastorino L; Sun A; Lu PJ; Zhou XZ; Balastik M; Finn G; Wulf G; Lim J; Li SH; Li X; Xia W; Nicholson LK; Lu KP
    Nature; 2006 Mar; 440(7083):528-34. PubMed ID: 16554819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IKKepsilon phosphorylation of estrogen receptor alpha Ser-167 and contribution to tamoxifen resistance in breast cancer.
    Guo JP; Shu SK; Esposito NN; Coppola D; Koomen JM; Cheng JQ
    J Biol Chem; 2010 Feb; 285(6):3676-3684. PubMed ID: 19940156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 directly binds and stabilizes Nrf2 in breast cancer.
    Saeidi S; Kim SJ; Guillen-Quispe YN; Jagadeesh ASV; Han HJ; Kim SH; Zhong X; Piao JY; Kim SJ; Jeong J; Shin YJ; Cha YJ; Lee HB; Han W; Min SH; Tian W; Kitamura H; Surh YJ
    FASEB J; 2022 Jan; 36(1):e22068. PubMed ID: 34918396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.